Collage photo of Michael Glickman and Andy Minn
Jun 14, 2025, 07:07
Michael Glickman and Andy Minn Have Been Appointed Co-Directors of the Marie-Josée Kravis CCI at MSK
Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“Congratulations to Dr. Michael Glickman, an infectious disease expert at Memorial Sloan Kettering Cancer Center (MSK), and Dr. Andy Minn, the incoming Chair of MSK’s new Immuno-Oncology Program, who will serve as Co-Directors of the Marie-Josée Kravis Center for Cancer Immunobiology (CCI), starting in August 2025.
Together, Dr. Glickman and Dr. Minn will lead the CCI in bringing together experts from a variety of disciplines at MSK to harness patient data and sponsor discoveries that will lead to new immunotherapy cures and treatments for people with cancer.”
More posts featuring Memorial Sloan Kettering Cancer Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2025, 19:13
Sep 6, 2025, 19:01
Sep 6, 2025, 18:05
Sep 6, 2025, 17:52
Sep 6, 2025, 17:48
Sep 6, 2025, 17:39
Sep 6, 2025, 17:28